Micron quarterly results and guidance significantly exceeded expectations, strategic customer agreements enhance earnings visibility, but the rating remains Neutral

Overview

This report reviews Micron Technology Inc.'s latest quarterly results, disclosure of strategic customer agreements, supply expansion plans, and Goldman Sachs' updated valuation and rating. The report believes Micron's results and guidance were clearly stronger than expected, and that the strategic customer agreements have significant positive implications for the stability of future earnings. However, because the current share price already reflects much of the good news, and because increased industry supply in 2027-2028 may weaken HBM pricing momentum, the rating remains Neutral.

Core views

The core views include: first, quarterly results and FY4Q guidance were both significantly above market expectations, indicating strong demand for DRAM, NAND, and HBM. Second, the strategic customer agreements include five-year take-or-pay revenue targets, partial floor and cap pricing arrangements, and customer prepayments, which help improve the sustainability of peak-cycle earnings and the valuation multiple the market is willing to assign. Third, the industry is accelerating supply additions to meet demand, but Goldman Sachs believes clearly loose supply conditions are unlikely to emerge at least before 2028. Fourth, despite healthy fundamentals, the risk of slower pricing momentum in 2027 from increased HBM supply keeps Goldman Sachs from turning more constructive for now.

Analysis framework

The report uses variance analysis versus Goldman Sachs forecasts and market consensus for results and guidance, combined with strategic customer agreement terms, capacity build-out pace, DRAM/NAND/HBM supply growth, capital expenditure plans, and valuation multiple assumptions to assess earnings sustainability and risk/reward. The target price is based on applying an 18x multiple to normalized EPS of $62.00.

Methodology notes

• equity_researchearnings_variance_analysis

  Earnings variance analysis

  Compares actual revenue, gross margin, non-GAAP EPS, and DRAM/NAND segment revenue against Goldman Sachs forecasts and market consensus to assess the magnitude of the earnings beat.

• Valuation methodsprice_target_multiple

  Price target multiple method

  The $1,100 target price is based on applying an 18x multiple to normalized EPS of $62.00; the multiple is unchanged, but the EPS assumption is raised due to higher confidence in earnings durability from revenue, margins, and customer agreements.

• proprietary_frameworkGS Factor Profile

  Goldman Sachs factor profile

  This framework compares a stock's percentile positioning relative to the market and sector peers across growth, financial returns, valuation multiples, and composite factors.

• proprietary_frameworkM&A Rank

  M&A probability score

  Goldman Sachs uses an M&A rank from 1 to 3 to assess the likelihood that a covered company becomes an acquisition target, where 1 represents high probability and 3 represents low probability.

• proprietary_databaseQuantum

  Financial history, forecast, and ratio database

  Quantum is Goldman Sachs' proprietary database used for deep single-company analysis and cross-company, cross-industry, and cross-market comparisons.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• MU.US

  subject_company

  Strengths

  Quarterly results significantly exceeded expectations, DRAM/NAND markets are healthy, HBM continues to ramp, and strategic customer agreements improve revenue and gross margin visibility.

  Weaknesses

  Current risk/reward is viewed as roughly balanced, and the share price already reflects much of the fundamental improvement.

  Comparison

  Revenue, gross margin, EPS, and FY4Q guidance were all above Goldman Sachs forecasts and market consensus.

  Risks

  Supply additions in 2027-2028 may slow HBM pricing momentum, and CXMT gaining DRAM share could affect pricing.

• SNDK

  positive_read_across

  Strengths

  Commentary on NAND supply dynamics is positive, and some NAND supply is being redirected toward the DRAM market, which is beneficial for NAND market health.

  Weaknesses

  The report does not provide detailed updates to SNDK's financial forecasts.

  Comparison

  As a Goldman Sachs-covered Buy-rated stock, it is expected to show a positive initial reaction to Micron-related commentary.

  Risks

  If NAND pricing and supply discipline are weaker than expected, the read-through would be reduced.

• LRCX

  semi_cap_equipment_beneficiary

  Strengths

  Micron raised FY26 CapEx guidance and expects higher FY27 CapEx, while earlier pull-ins of cleanroom and equipment spending support semiconductor equipment demand.

  Weaknesses

  The degree of benefit depends on Micron's actual capital spending execution and order timing.

  Comparison

  The report lists LRCX as one of the main semiconductor equipment names with positive read-through.

  Risks

  If industry supply expansion is too fast or demand slows, equipment orders may become volatile.

• AMAT

  semi_cap_equipment_beneficiary

  Strengths

  Micron's capacity expansion and equipment pull-ins provide a positive signal for equipment companies such as AMAT.

  Weaknesses

  The report does not separately quantify AMAT's earnings sensitivity.

  Comparison

  Similar to LRCX, AMAT is viewed as a potential beneficiary of the upward revision to FY26/FY27 CapEx.

  Risks

  Delays in capital spending plans, changes in customer demand, or a cyclical downturn could affect realization of the benefit.

Key data

• RatingNeutralGoldman Sachs maintains a Neutral rating on MU.
• Target price$1,100Raised from $900, based on an 18x multiple and normalized EPS of $62.00.
• Quarterly revenue$41.46bnAbove Goldman Sachs forecast of $37.58bn and market expectation of $36.28bn.
• Quarterly gross margin84.9%Above Goldman Sachs forecast of 83.4% and market expectation of 82.5%.
• Quarterly non-GAAP EPS$25.11Above Goldman Sachs forecast of $22.07 and market expectation of $21.05.
• DRAM revenue$31.33bnAbove Goldman Sachs forecast of $28.30bn and market expectation of $28.21bn.
• NAND revenue$9.94bnAbove Goldman Sachs forecast of $9.18bn and market expectation of $7.77bn.
• Number of strategic customer agreements16Covering data center, consumer, automotive, and other end markets.
• Customer prepayments$22bnTotal upfront customer deposits attached to the strategic customer agreements.
• Five-year committed revenueapproximately $100bnCalculated at floor prices, with gross margins above previous peak levels, in the low 60% range.
• Agreement-covered shipment volumeDRAM approximately 20%, NAND approximately 30%The company ultimately aims to cover about 50% of expected revenue.
• FY4Q revenue guidance$50.00bn midpointAbove Goldman Sachs forecast of $48.77bn and market expectation of $43.34bn.
• FY4Q non-GAAP EPS guidance$30.00-$32.00, midpoint $31.00Above Goldman Sachs forecast of $29.95 and market expectation of $25.77.
• FY27 CapEx model$50bnRising sequentially from the FY4Q26 CapEx base of $10bn, with about half of the FY27 increase supporting HBM and conventional DRAM capacity expansion.
• CY26 DRAM bit supply growthlow-to-mid-20%Higher than the company's prior view.
• CY26 NAND bit supply growthapproximately 20%In line with industry growth.

Impact & implications

The direct impact on MU is positive: stronger results, raised guidance, and strategic customer agreements may increase market recognition of the sustainability of peak earnings, thereby supporting the valuation multiple. Spillover effects on peers and the supply chain are also positive. The report expects SNDK to benefit from commentary on NAND supply and demand, while semiconductor equipment companies such as LRCX and AMAT may see positive read-through from Micron's higher FY26/FY27 CapEx and earlier pull-ins of cleanroom and equipment spending.

Risks

• A significant increase in HBM supply in 2027 and 2028 could slow HBM pricing momentum.
• If industry supply discipline weakens, the current healthy supply-demand balance in DRAM and NAND could deteriorate.
• CXMT's continued gains in DRAM market share could negatively affect pricing dynamics.
• If HBM content in AI accelerators is lower than currently expected, the upside scenario would weaken.
• The actual coverage ratio, floor-price protection, and customer execution under strategic customer agreements still need continued verification.

What to watch

• Whether the industry can maintain supply growth discipline in 2028 and beyond.
• Whether Micron continues to disclose more customer agreements and further strengthens business floor pricing and revenue visibility.
• HBM4 shipment ramp, HBM roadmap execution, and share changes.
• The execution pace of FY27 CapEx increasing from the $10bn base toward the $50bn model assumption.
• The production ramp and expansion progress of the Idaho, Singapore, Hiroshima, and New York fabs.
• Whether NAND supply continues to be redirected toward the DRAM market and whether NAND market health is maintained.